Cargando…

Malignant ascite-derived extracellular vesicles inhibit T cell activity by upregulating Siglec-10 expression

Background and purpose: To evade immune defense, cancer cells can employ extracellular vesicles (EVs) to inhibit the anti-tumor activity of lymphocytes in the tumor microenvironment. However, the mechanisms and key molecules that mediate the effects of EVs on lymphocytes are unclear. Patients and me...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Yujuan, Zhou, Jing, Zhuo, Qian, Zhang, Jingyun, Xie, Jingyan, Han, Suping, Zhao, Shuli
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681125/ https://www.ncbi.nlm.nih.gov/pubmed/31534365 http://dx.doi.org/10.2147/CMAR.S210568

Ejemplares similares

Molecular cloning of porcine Siglec-3, Siglec-5 and Siglec-10, and identification of Siglec-10 as an alternative receptor for porcine reproductive and respiratory syndrome virus (PRRSV)
por: Xie, Jiexiong, et al.
Publicado: (2017)

Comparative Gene Expression Analysis of Lymphocytes Treated with Exosomes Derived from Ovarian Cancer and Ovarian Cysts
por: Li, Yujuan, et al.
Publicado: (2017)

Siglec-6 mediates the uptake of extracellular vesicles through a noncanonical glycolipid binding pocket
por: Schmidt, Edward N., et al.
Publicado: (2023)

Small extracellular vesicles from malignant ascites of patients with advanced ovarian cancer provide insights into the dynamics of the extracellular matrix
por: Bortot, Barbara, et al.
Publicado: (2021)

Comparison of benign peritoneal fluid- and ovarian cancer ascites-derived extracellular vesicle RNA biomarkers
por: Yamamoto, Cindy M., et al.
Publicado: (2018)

Extracellular vesicles derived from ascitic fluid enhance growth and migration of ovarian cancer cells
por: Mitra, Aparna, et al.
Publicado: (2021)

Ascites-derived CDCP1+ extracellular vesicles subcluster as a novel biomarker and therapeutic target for ovarian cancer
por: Kong, Lingnan, et al.
Publicado: (2023)

Unveiling Molecular Recognition of Sialoglycans by Human Siglec-10
por: Forgione, Rosa Ester, et al.
Publicado: (2020)

Unveiling Molecular Recognition of Sialoglycans by Human Siglec-10
por: Forgione, Rosa Ester, et al.
Publicado: (2020)

Dissemination of Mycobacterium tuberculosis is associated to a SIGLEC1 null variant that limits antigen exchange via trafficking extracellular vesicles
por: Benet, Susana, et al.
Publicado: (2021)

Extracellular Vesicles in Hepatobiliary Malignancies
por: Lapitz, Ainhoa, et al.
Publicado: (2018)

Extracellular vesicles in urological malignancies
por: Rimmer, Michael P., et al.
Publicado: (2021)

Lysates of Lactobacillus acidophilus combined with CTLA-4-blocking antibodies enhance antitumor immunity in a mouse colon cancer model
por: Zhuo, Qian, et al.
Publicado: (2019)

Siglec Ligands
por: Gonzalez-Gil, Anabel, et al.
Publicado: (2021)

Siglec10—An immunosuppressor and negative predictor of survival prognosis in gliomas
por: Wang, Hesong, et al.
Publicado: (2022)

FASN Is a Biomarker Enriched in Malignant Glioma-Derived Extracellular Vesicles
por: Ricklefs, Franz L., et al.
Publicado: (2020)

Contribution of Tumor-Derived Extracellular Vesicles to Malignant Transformation of Normal Cells
por: Chulpanova, Daria S., et al.
Publicado: (2022)

Preferential use of Siglec-1 or Siglec-10 by type 1 and type 2 PRRSV strains to infect PK15(S1–CD163) and PK15(S10–CD163) cells
por: Xie, Jiexiong, et al.
Publicado: (2018)

Functional Inhibitory Siglec-6 Is Upregulated in Human Colorectal Cancer-Associated Mast Cells
por: Yu, Yingxin, et al.
Publicado: (2018)

Role of Extracellular Vesicles in Hematological Malignancies
por: Raimondo, Stefania, et al.
Publicado: (2015)

The Roles of Extracellular Vesicles in Malignant Melanoma
por: Cheng, Ying-Chen, et al.
Publicado: (2021)

Mechanism of ozone alleviation of malignant ascites in hepatocellular carcinoma through the inhibition of neutrophil extracellular traps
por: Han, Feng, et al.
Publicado: (2023)

Coevolution of Siglec-11 and Siglec-16 via gene conversion in primates
por: Hayakawa, Toshiyuki, et al.
Publicado: (2017)

The function and clinical application of extracellular vesicles in innate immune regulation
por: Zhou, Xiaoxue, et al.
Publicado: (2020)

Platelet-derived extracellular vesicles inhibit ferroptosis and promote distant metastasis of nasopharyngeal carcinoma by upregulating ITGB3
por: Li, Fei, et al.
Publicado: (2022)

Research progress of tumor‐derived extracellular vesicles in the treatment of malignant pleural effusion
por: Zhang, Sijia, et al.
Publicado: (2022)

Sialic acids in pancreatic cancer cells drive tumour-associated macrophage differentiation via the Siglec receptors Siglec-7 and Siglec-9
por: Rodriguez, Ernesto, et al.
Publicado: (2021)

Altered Proteome of Extracellular Vesicles Derived from Bladder Cancer Patients Urine
por: Lee, Jingyun, et al.
Publicado: (2018)

Malignant ascites supernatant enhances the proliferation of gastric cancer cells partially via the upregulation of asparagine synthetase
por: Jiao, Yuan, et al.
Publicado: (2023)

Focus on Extracellular Vesicles: Therapeutic Potential of Stem Cell-Derived Extracellular Vesicles
por: Zhang, Bin, et al.
Publicado: (2016)

Emerging Role of Mesenchymal Stromal Cell-Derived Extracellular Vesicles in Pathogenesis of Haematological Malignancies
por: Cominal, Juçara Gastaldi, et al.
Publicado: (2019)

Determination of the optimal volume of ascitic fluid for the precise diagnosis of malignant ascites
por: Zhang, Feifei, et al.
Publicado: (2019)

Nano‐LYTACs for Degradation of Membrane Proteins and Inhibition of CD24/Siglec‐10 Signaling Pathway
por: Wang, Kun, et al.
Publicado: (2023)

Nano‐LYTACs for Degradation of Membrane Proteins and Inhibition of CD24/Siglec‐10 Signaling Pathway
por: Wang, Kun, et al.
Publicado: (2023)

Monocyte Siglec-14 expression is upregulated in patients with systemic lupus erythematosus and correlates with lupus disease activity
por: Thornhill, Susannah I., et al.
Publicado: (2017)

Siglecs at the Host–Pathogen Interface
por: Chang, Yung-Chi, et al.
Publicado: (2020)

Siglecs as Therapeutic Targets in Cancer
por: Lim, Jackwee, et al.
Publicado: (2021)

Siglec Signaling in the Tumor Microenvironment
por: van Houtum, Eline J. H., et al.
Publicado: (2021)

Oncolytic adenovirus inhibits malignant ascites of advanced ovarian cancer by reprogramming the ascitic immune microenvironment
por: Shi, Gang, et al.
Publicado: (2021)

Quantum dot-based multiplexed imaging in malignant ascites: a new model for malignant ascites classification
por: Zeng, Wei-Juan, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_bqlfofh895vc9re7f5t4m7pu57